ARTICLE | Discovery & Translation
BioCentury’s roundup of translational innovations also includes synthetic gene regulators, three longevity genes and more
By Danielle Golovin, Senior Biopharma Analyst
October 31, 2024 11:53 PM UTC
In back-to-back Nature papers, independent groups revealed that intervening in macrophage-fibroblast cross-talk could reduce cardiac fibrosis. Both groups found that IL-1β signaling from specific macrophage populations activates fibroblasts, and reinforced the role of the fibroblast transcription factor MEOX1 as a key regulator of heart failure.
Amgen Inc. (NASDAQ:AMGN) and collaborators at Washington University School of Medicine in St. Louis identified a disease-associated fibroblast trajectory using multi-omic data from 45 healthy donor, acutely infarcted and chronically failing human hearts…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/653990/science-spotlight-macrophage-fibroblast-cross-talk-in-heart-failure